A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 - Nature Genetics
- ️Schreiber, Stefan
- ️Sun Dec 31 2006
Accession codes
Accessions
GenBank/EMBL/DDBJ
References
Hugot, J.P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599–603 (2001).
Ogura, Y. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603–606 (2001).
Rioux, J.D. et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat. Genet. 29, 223–228 (2001).
Peltekova, V.D. et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat. Genet. 36, 471–475 (2004).
Stoll, M. et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat. Genet. 36, 476–480 (2004).
Brant, S.R. et al. MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am. J. Hum. Genet. 73, 1282–1292 (2003).
Ho, G.T. et al. ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach. Hum. Mol. Genet. 15, 797–805 (2006).
Schwab, M. et al. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology 124, 26–33 (2003).
McGovern, D.P. et al. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum. Mol. Genet. 14, 1245–1250 (2005).
Yamazaki, K. et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum. Mol. Genet. 14, 3499–3506 (2005).
Duerr, R.H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461–1463 (2006).
Maeda, S. et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 307, 734–738 (2005).
Kobayashi, K.S. et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307, 731–734 (2005).
Girardin, S.E. et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278, 8869–8872 (2003).
Hampe, J. et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357, 1925–1928 (2001).
Watanabe, T., Kitani, A., Murray, P.J. & Strober, W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat. Immunol. 5, 800–808 (2004).
Smyth, D.J. et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat. Genet. 38, 617–619 (2006).
Duerr, R.H., Barmada, M.M., Zhang, L., Pfutzer, R. & Weeks, D.E. High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11–12. Am. J. Hum. Genet. 66, 1857–1862 (2000).
Hampe, J. et al. A genome-wide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am. J. Hum. Genet. 64, 808–816 (1999).
Shaw, S.H. et al. Stratification by CARD15 variant genotype in a genome-wide search for inflammatory bowel disease susceptibility loci. Hum. Genet. 113, 514–521 (2003).
Croucher, P.J.P. et al. Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur. J. Hum. Genet. 11, 6–16 (2003).
Zheng, H. et al. Cloning and analysis of human Apg16L. DNA Seq. 15, 303–305 (2004).
Mizushima, N. et al. Mouse Apg16L, a novel WD-repeat protein, targets to the autophagic isolation membrane with the Apg12-Apg5 conjugate. J. Cell Sci. 116, 1679–1688 (2003).
Hampe, J. et al. An integrated system for high throughput TaqMan based SNP genotyping. Bioinformatics 17, 654–655 (2001).
Hampe, J. et al. Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p. Proc. Natl. Acad. Sci. USA 99, 321–326 (2002).
Venter, J.C. et al. The sequence of the human genome. Science 291, 1304–1351 (2001).
Manaster, C. et al. InSNP: a tool for automated detection and visualization of SNPs and InDels. Hum. Mutat. 26, 11–19 (2005).
Barrett, J.C., Fry, B., Maller, J. & Daly, M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263–265 (2005).
Franke, A. et al. GENOMIZER: an integrated analysis system for genome-wide association data. Hum. Mutat. 27, 583–588 (2006).
Dudbridge, F. Pedigree disequilibrium tests for multilocus haplotypes. Genet. Epidemiol. 25, 115–121 (2003).
Acknowledgements
We thank all affected individuals, families and physicians for their cooperation. We acknowledge the cooperation of the German Crohn and Colitis Patient Association (Deutsche Morbus Crohn und Colitis Vereinigung) and the contributing gastroenterologists. The authors thank T. Wesse, B. Petersen, L. Bossen, T. Henke, S. Ehlers, A. Dietsch, T. Kaacksteen and D. Soars for technical help. The ongoing technical and logistic support and helpful discussions with A. Toeppel, C.R. Scafe, A. Kejariwal, H.M. Wenz, M. Rhodes, S. Short, T. Woodage and D.A. Gilbert from Applied Biosystems is especially acknowledged. We thank C.-C. Chiang for preparing the submission of new SNPs to dbSNP. T.H. Karlsen (Rikshospitalet) is acknowledged for helpful discussions. We thank A. Forbes, J. Sanderson and S. Fisher for case ascertainment and establishment of the UK Crohn disease database. We acknowledge use of genotype data from the British 1958 Birth Cohort DNA collection, funded by Medical Research Council grant G0000934 and Wellcome Trust grant 068545/Z/02. This study was supported by the German Ministry of Education and Research (BMBF) through the National Genome Research Network (environmental diseases network and SMP-GEM), the POPGEN biobank, the analysis infrastructure and methods of the MediGrid project and the German Research Council (Ha 3091/1-1, 2-1), Applied Biosystems, TECAN, the Wellcome Trust and CORE (UK).
Author information
Author notes
Jochen Hampe and Andre Franke: These authors contributed equally to this work.
Authors and Affiliations
Institute for Clinical Molecular Biology, Christian-Albrechts University Kiel, University Hospital Schleswig-Holstein, Kiel, 24105, Germany
Jochen Hampe, Andre Franke, Philip Rosenstiel, Andreas Till, Markus Teuber, Robert Häsler & Stefan Schreiber
First Department of Medicine, Christian-Albrechts University Kiel, University Hospital Schleswig-Holstein, Kiel, 24105, Germany
Jochen Hampe, Ulrich R Fölsch & Stefan Schreiber
Genome Analysis Group, Leibniz Institute for Age Research, Fritz Lipmann Institute, Beutenbergstrasse 11, Jena, 07745, Germany
Klaus Huse & Matthias Platzer
Max Planck Institute for Informatics, Stuhlsatzenhausweg 85, Saarbrücken, 66123, Germany
Mario Albrecht, Gabriele Mayr & Thomas Lengauer
Applied Biosystems, 850 Lincoln Center Drive, Foster City, 94404, California, USA
Francisco M De La Vega, Jason Briggs & Simone Günther
Department of Medical and Molecular Genetics, King's College London School of Medicine, London, SE1 9RT, UK
Natalie J Prescott, Clive M Onnie & Christopher G Mathew
Department of Pathology, Christian-Albrechts University Kiel, University Hospital Schleswig-Holstein, Kiel, 24105, Germany
Bence Sipos
Institute of Medical Informatics and Statistics, Christian-Albrechts University Kiel, University Hospital Schleswig-Holstein, Kiel, 24105, Germany
Michael Krawczak
Max-Planck Institute for Molecular Genetics, Ihnestr. 63, Berlin, 14195, Germany
Philip Rosenstiel
Authors
- Jochen Hampe
You can also search for this author in PubMed Google Scholar
- Andre Franke
You can also search for this author in PubMed Google Scholar
- Philip Rosenstiel
You can also search for this author in PubMed Google Scholar
- Andreas Till
You can also search for this author in PubMed Google Scholar
- Markus Teuber
You can also search for this author in PubMed Google Scholar
- Klaus Huse
You can also search for this author in PubMed Google Scholar
- Mario Albrecht
You can also search for this author in PubMed Google Scholar
- Gabriele Mayr
You can also search for this author in PubMed Google Scholar
- Francisco M De La Vega
You can also search for this author in PubMed Google Scholar
- Jason Briggs
You can also search for this author in PubMed Google Scholar
- Simone Günther
You can also search for this author in PubMed Google Scholar
- Natalie J Prescott
You can also search for this author in PubMed Google Scholar
- Clive M Onnie
You can also search for this author in PubMed Google Scholar
- Robert Häsler
You can also search for this author in PubMed Google Scholar
- Bence Sipos
You can also search for this author in PubMed Google Scholar
- Ulrich R Fölsch
You can also search for this author in PubMed Google Scholar
- Thomas Lengauer
You can also search for this author in PubMed Google Scholar
- Matthias Platzer
You can also search for this author in PubMed Google Scholar
- Christopher G Mathew
You can also search for this author in PubMed Google Scholar
- Michael Krawczak
You can also search for this author in PubMed Google Scholar
- Stefan Schreiber
You can also search for this author in PubMed Google Scholar
Contributions
J.H. and A.F. established the genotyping and analysis methodology; A.F. performed the genotyping and association analysis and contributed to the writing of the manuscript; S.S. supervised the patient recruitment; J.H. recruited the German patients and drafted the manuscript; P.R., A.T., A.F., K.H., R.H., B.S. and M.P. performed the protein, immunohistochemistry and cDNA experiments; M.T. provided LIMS programming support; M.A., G.M. and T.L. performed in silico protein analysis and contributed to writing the manuscript; F.D.L.V. designed the cSNP panel and genotyping assays and contributed to the manuscript; J.B. and S.G. helped establish the SNPlex automation system; N.P., C.O. and C.M. performed the replication experiment in the UK samples; U.F. contributed to the design and the writing of the paper; M.K. provided genetic epidemiology consulting, performed the interaction analysis and helped draft the manuscript; and J.H. and S.S. jointly designed and supervised the experiment.
Corresponding authors
Correspondence to Jochen Hampe or Stefan Schreiber.
Ethics declarations
Competing interests
A patent application has been filed regarding ATG16L1 as a susceptibility gene for Crohn disease.
Supplementary information
Rights and permissions
About this article
Cite this article
Hampe, J., Franke, A., Rosenstiel, P. et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39, 207–211 (2007). https://doi.org/10.1038/ng1954
Received: 31 July 2006
Accepted: 05 December 2006
Published: 31 December 2006
Issue Date: 01 February 2007
DOI: https://doi.org/10.1038/ng1954